Health Outcomes with Curative and Palliative Therapies in Real World: Role of the Quality of Life Summary Score in Thoracic Oncology Patients.
Kurt G TournoyValerie AdamInge MuylleHelene De RijckEllen EveraertEhsan EqlimiJan P van MeerbeeckPiet VercauterPublished in: Cancers (2023)
Patients with thoracic malignancies treated with curative intent experience a worsening of their QOL in the first year, whereas those receiving palliative anti-cancer therapy do not. QOL one year after the start of therapy depends on the baseline health scores as determined by the patient, comorbidity burden, and therapeutic strategy. Survival depends on therapeutic strategy and early hospitalization due to toxicity.
Keyphrases
- palliative care
- prognostic factors
- cancer therapy
- end stage renal disease
- newly diagnosed
- spinal cord
- healthcare
- ejection fraction
- chronic kidney disease
- public health
- rectal cancer
- advanced cancer
- mental health
- oxidative stress
- drug delivery
- case report
- stem cells
- patient reported outcomes
- climate change
- spinal cord injury
- health information
- health promotion
- free survival